Title: “Apelin Analogs as Novel Biologics for Cardiovascular Disease”
Who: Dr. Gavin Oudit, founder, PEARKO Therapeutics
Date: Tuesday, June 15
Time: 11 a.m. – Noon
Pre-register at: https://explore.zoom.us/docs/en-us/events.html
* ECHO is an entrepreneurship training program, funded and organized in a partnership between the Translational Biology and Engineering Program (TBEP), the University of Toronto component of the Ted Rogers Centre for Heart Research, and the Health Innovation Hub (H2i).